Sabre (SABR): Constellation’s most asymmetric bet
Sabre’s $4.6 billion debt load and 2029-30 maturities frame Constellation Software’s 12.7% PEMS stake, despite management’s 9% annual EBITDA growth target through 2030.
Sabre’s $4.6 billion debt load and 2029-30 maturities frame Constellation Software’s 12.7% PEMS stake, despite management’s 9% annual EBITDA growth target through 2030.
@MBrooks87621 $tenb
Activist Nelson Peltz Walked Away From the Investment He Loved Most. Now He’s Back. $WEN
@BryanFaulkCPA I bought the $PSA preferred and the $VNO preferred recently They have pretty good price appreciation on top on the solid yield now
Bear thesis for $HPP studio biz
Adient has $435 million of buyback capacity, equal to 38% of its market value, after adding $400 million to its repurchase program.
Knife River expects FY26 EBITDA margin to fall 138 basis points as project delays and fuel costs bite, while Sharper EDGE targets…
AST SpaceMobile’s 79% decline improves its risk-reward case, but satellite deployment delays, rising costs and Blacklift commitments raise…
India’s 236 GWh battery target boosts local electrolyte-salt makers, while Mirion’s radiation monitors and Overwatch’s passive drone…
Remitly’s Q3 revenue growth accelerated to 22% as lower transaction losses lifted margins, while recipient-facing products build a…
Dave & Buster’s faces fourteen straight quarters of same-store sales declines, shrinking margins and a new CEO’s turnaround plan after…
Chord Energy trades at 3x mid-cycle EV/EBITDA with a 15% free-cash-flow yield at $75 WTI, while repurchasing shares and expanding its…
Qualstar targets 8% revenue growth in 2027 and 12% in 2028 as AI-driven storage demand and LTO-10 replacement cycles revive tape libraries.
GFL’s halted sale process sets a $52 to $58 per-share range, while its Secure acquisition could redirect investor attention toward…
Euroseas’ feeder-vessel renewals and contracted cash flow support higher 2027 earnings, while Red Sea normalization, vessel values and…
BNTC · long Benitec Biopharma's BB-301 gene therapy is in a Phase 1b/2a trial for an ultra-rare muscular dystrophy.
Gatekeeper Systems’ revenue rebound is overshadowed by $19.3 million in nine-month operating cash burn, swelling inventory and overdue…
Smart Shooter sells AI-enabled rifle sights that track drones and release shots only when likely to hit, trading near 55 times likely 2025…
RIN prices near all-time highs reflect tighter renewable-fuel mandates, a shrinking credit bank, and biodiesel production shortfalls.
United Parks trades at 8x EBITDA with an 8%+ unlevered cash yield, aggressive buybacks and roughly 80% effective short interest, while…
Braemar’s BHR-PB preferred trades near $13 against a $25 liquidation preference, yielding 10% amid hotel sales, a $480 million Ashford…
Semiconductor optical amplifiers offer compact, low-cost gain for LiDAR, long-haul links and ultra-high-power co-packaged optics, trading…
Diversified Energy (DEC) has paid $21.84 per share in dividends since June 2017 and trades at $13.35 amid a bullish U.S.
Energy & Environmental Services, EESE, pairs a shareholder-led board overhaul and subsidiary divestiture with rising drilling activity,…
Groupon is building an AI “Brain” to personalize its app for each user, turning its turnaround plan into a product initiative.
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.